Hjem › Hjertesvigt › Oregon
Hjertesvigt kliniske forsøg i Oregon
17 studier for Hjertesvigt søger deltagere på steder i Oregon.
Byer i Oregon
Officiel studietekst (engelsk)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Portland
RekruttererFase 3
Alder 18 til 130 · Alle køn · Opdateret 2. okt. 2026 · NCT06307652Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Oregon Health and Science University, Portland
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 24. sep. 2026 · NCT06736574Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Oregon Health & Science University, Portland
Rekrutterer
Alder 18 til 100 · Alle køn · Opdateret 9. sep. 2026 · NCT06310031AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Oregon Health and Science University, Portland
RekruttererFase 2
Alder 40 til 85 · Alle køn · Opdateret 27. aug. 2026 · NCT06793371Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
- Research Site, Portland
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT07690436A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Oregon Health & Science University, Portland
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07567001CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- VA Portland Health Care System, Portland, OR, Portland
Rekrutterer
Alder 60 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT05996328Assessment of CCM in HF With Higher Ejection Fraction
- Providence Heart & Vascular, Portland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT05064709PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence St. Vincent's - Portland, Portland
- Oregon Health Science Portland, Portland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT05934487Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Oregon Health & Science University, Portland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 10. jun. 2026 · NCT06526195CCM OPEN HF Registry
- Providence St. Vincent Medical Center, Portland
- Legacy Medical Group Cardiology, Portland
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. apr. 2026 · NCT07112924The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oregon Health & Science University (OHSU), Portland
- Providence Heart Institute, Portland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 13. apr. 2026 · NCT03142152Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Oregon Health and Science University, Portland
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 24. mar. 2026 · NCT06217302Left vs Left Randomized Clinical Trial
- Oregon Health & Science University, Portland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2025 · NCT05650658Cardiogenic Shock Working Group Registry
- Providence St. Vincent Heart Clinic, Portland
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 6. jun. 2025 · NCT04682483Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
- Oregon Health & Science University, Portland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 21. mar. 2025 · NCT06461962HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
- Providence Heart Institute, Portland
RekruttererObservationsstudie
Alder 18 til 100 · Alle køn · Opdateret 22. maj 2024 · NCT06425848Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.